PF-07275315

PF-07275315 · Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PF-07275315, covering 2025-05-25 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2, Phase 3]

See pricing